Shih et al. Selley ML. 2003. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer’s dis- ease. Neurobiol Aging 24(7):903–907. Shih RA, Glass TA, Bandeen-Roche K, Carlson MC, Bolla KI, Todd AC, et al. 2006. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology 67(9):1556–1562. Skoog I, Gustafson D. 2006. Update on hypertension and Alzheimer’s disease. Neurol Res 28(6):605–611. Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X, et al. 2006. Past adult lead exposure is linked to neurodegen- eration measured by brain MRI. Neurology 66(10):1476–1484. Stewart WF, Schwartz BS, Simon D, Bolla KI, Todd AC, Links J. 1999. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology 52(8):1610–1617. Stewart WF, Schwartz BS, Simon D, Kelsey K, Todd AC. 2002. ApoE genotype, past adult lead exposure, and neurobehav- ioral function. Environ Health Perspect 110:501–505. Stokes L, Letz R, Gerr F, Kolczak M, McNeill FE, Chettle DR, et al. 1998. Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med 55(8):507–516. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. 1999. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem 73(6):2613–2616. Weingartner H, Cohen RM, Murphy DL, Martello J, Gerdt C. 1981. Cognitive processes in depression. Arch Gen Psychiatry 38(1):42–47. Weiss B, Bellinger DC. 2006. Social ecology of children’s vulnera- bility to environmental pollutants. Environ Health Perspect 114:1479–1485. Weisskopf MG, Proctor SP, Wright RO, Schwartz J, Spiro A III, Sparrow D, et al. 2007. Cumulative lead exposure and cogni- tive performance among elderly men. Epidemiology 18(1):59–56. Weisskopf MG, Wright RO, Schwartz J, Spiro A III, Sparrow D, Aro A, et al. 2004. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol 160(12):1184–1193. Widzowski DV, Cory-Slechta DA. 1994. Homogeneity of regional brain lead concentrations. Neurotoxicology 15(2):295–307. Wilson RS, Beckett LA, Barnes LL, Schneider JA, Bach J, Evans DA, et al. 2002. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 17(2): 179–193. Wright RO, Tsaih SW, Schwartz J, Spiro A III, McDonald K, Weiss ST, et al. 2003. Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 14(6):713–718. Yankner BA. 1996. Mechanisms of neuronal degeneration in Alzheimer’s disease. Neuron 16(5):921–932. Zawia NH, Crumpton T, Brydie M, Reddy GR, Razmiafshari M. 2000. Disruption of the zinc ﬁnger domain: a common target that underlies many of the effects of lead. Neurotoxicology 21(6):1069–1080. Zubenko GS, Stifﬂer S, Stabler S, Kopp U, Hughes HB, Cohen BM, et al. 1994. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer’s disease. Am J Med Genet 54(3):199–205. 492 VOLUME 115 | NUMBER 3 | March 2007 • Environmental Health Perspectives